| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3969159 | Progresos de Obstetricia y Ginecología | 2009 | 9 Pages |
Abstract
The residual disease after the completion of cytorreductive surgery and adjuvant chemotherapy has prognostic importance and its management is not well established.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Joan Manel Gasent Blesa, Vicente Alberola Candel, Javier Rius Jordà ,